Difebarbamate
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.036.147 |
Chemical and physical data | |
Formula | C28H42N4O9 |
Molar mass | 578.663 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Difebarbamate (INN) is a tranquilizer of the barbiturate and carbamate families which is used in Europe as a component of a combination drug formulation referred to as tetrabamate (Atrium, Sevrium).[1][2][3]
See also
References
- ↑ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 333. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
- ↑ World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
- ↑ Vachta J, Valter K, Siegfried B (1990). "Metabolism of difebarbamate in man". European Journal of Drug Metabolism and Pharmacokinetics. 15 (3): 191–8. doi:10.1007/BF03190203. PMID 2253648. S2CID 2916646.
Skeletal muscle relaxants (M03) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peripherally acting (primarily antinicotinic, NMJ block) |
| ||||||||||||||
Centrally acting |
| ||||||||||||||
Directly acting |
Alcohols |
|
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.